Stock OMI OWENS & MINOR, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Owens & Minor, Inc.

Equities

OMI

US6907321029

Medical Equipment, Supplies & Distribution

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
25.09 USD +4.02% Intraday chart for Owens & Minor, Inc. +1.21% +30.20%
Apr. 10 Baird Raises Owens & Minor's Price Target to $28 From $24, Maintains Neutral Rating MT
Feb. 29 Owens & Minor Insider Sold Shares Worth $250,000, According to a Recent SEC Filing MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 324.9 1,989 3,282 1,489 1,474 1,922 - -
Enterprise Value (EV) 1 1,766 2,891 4,174 3,902 3,122 3,597 3,360 3,091
P/E ratio -5.02 x 57.6 x 14.8 x 67.3 x -35.7 x 167 x 27.7 x 18.4 x
Yield 0.19% 0.04% 0.02% - - 0.02% 0.02% 0.02%
Capitalization / Revenue 0.04 x 0.23 x 0.34 x 0.15 x 0.14 x 0.18 x 0.18 x 0.17 x
EV / Revenue 0.19 x 0.34 x 0.43 x 0.39 x 0.3 x 0.34 x 0.31 x 0.27 x
EV / EBITDA 7.83 x 8.63 x 8.48 x 7.54 x 5.94 x 6.28 x 5.36 x 4.52 x
EV / FCF 15.5 x 10.3 x 56 x 24.6 x 5.86 x 17.4 x 11.3 x 9.13 x
FCF Yield 6.45% 9.68% 1.78% 4.06% 17.1% 5.74% 8.85% 11%
Price to Book 0.68 x 2.41 x 3.5 x 1.57 x 1.58 x 1.99 x 1.75 x 1.52 x
Nbr of stocks (in thousands) 62,852 73,512 75,456 76,234 76,501 76,598 - -
Reference price 2 5.170 27.05 43.50 19.53 19.27 25.09 25.09 25.09
Announcement Date 3/4/20 2/24/21 2/23/22 2/28/23 2/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 9,211 8,480 9,785 9,955 10,334 10,660 10,947 11,291
EBITDA 1 225.7 335.2 492.3 517.8 525.8 572.8 627.4 683.7
EBIT 1 153 283.4 442.4 369.1 304.7 329.8 371.7 406
Operating Margin 1.66% 3.34% 4.52% 3.71% 2.95% 3.09% 3.4% 3.6%
Earnings before Tax (EBT) 1 -28.72 109.9 276.8 10.89 -54.73 20.9 124.9 230
Net income 1 -62.37 29.87 221.6 22.39 -41.3 4.8 90.6 129.9
Net margin -0.68% 0.35% 2.26% 0.22% -0.4% 0.05% 0.83% 1.15%
EPS 2 -1.030 0.4700 2.940 0.2900 -0.5400 0.1500 0.9067 1.365
Free Cash Flow 1 113.9 280 74.49 158.4 532.8 206.5 297.5 338.5
FCF margin 1.24% 3.3% 0.76% 1.59% 5.16% 1.94% 2.72% 3%
FCF Conversion (EBITDA) 50.44% 83.54% 15.13% 30.59% 101.34% 36.05% 47.42% 49.51%
FCF Conversion (Net income) - 937.46% 33.61% 707.6% - 4,302.08% 328.37% 260.59%
Dividend per Share 2 0.0100 0.0100 0.0100 - - 0.004000 0.004000 0.005000
Announcement Date 3/4/20 2/24/21 2/23/22 2/28/23 2/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 2,502 2,467 2,407 2,500 2,497 2,551 2,523 2,563 2,592 2,656 2,610 2,642 2,672 2,736 2,638
EBITDA 1 91.67 97.38 118.5 155.6 127 116.7 108.7 112.8 134.7 169.6 121 136.7 147.1 168.8 130.9
EBIT 1 79.28 84.86 104.9 113.6 83.45 67.16 47.67 62 84.24 110.8 57.25 75.19 84.19 104.7 68.63
Operating Margin 3.17% 3.44% 4.36% 4.54% 3.34% 2.63% 1.89% 2.42% 3.25% 4.17% 2.19% 2.85% 3.15% 3.83% 2.6%
Earnings before Tax (EBT) 1 - - - - - - - - - 21 -17.17 -3.63 8.364 33.34 -
Net income 1 44.13 41.98 39.28 28.6 12.5 -57.99 -24.42 -28.24 -6.426 17.78 -15.5 -1.3 4 17.5 4.3
Net margin 1.76% 1.7% 1.63% 1.14% 0.5% -2.27% -0.97% -1.1% -0.25% 0.67% -0.59% -0.05% 0.15% 0.64% 0.16%
EPS 2 0.5800 0.5500 0.5200 0.3700 0.1600 -0.7700 -0.3200 -0.3700 -0.0800 0.2300 -0.2000 -0.003330 0.0833 0.2700 0.0500
Dividend per Share 2 0.002500 0.002500 0.002500 0.002500 0.002500 - - - - - - - - - -
Announcement Date 11/3/21 2/23/22 5/3/22 8/3/22 11/2/22 2/28/23 5/5/23 8/4/23 11/3/23 2/20/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,441 903 892 2,414 1,648 1,676 1,438 1,169
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 6.386 x 2.694 x 1.812 x 4.661 x 3.134 x 2.925 x 2.293 x 1.71 x
Free Cash Flow 1 114 280 74.5 158 533 207 298 339
ROE (net income / shareholders' equity) 6.93% 24.5% 26.9% 19.5% 11.3% 12.9% 15.1% 16.1%
ROA (Net income/ Total Assets) 0.92% 4.12% 6.45% 4.13% 2.01% 4.32% 4.96% 5.53%
Assets 1 -6,803 725.6 3,436 542.4 -2,051 111.2 1,828 2,349
Book Value Per Share 2 7.630 11.20 12.40 12.40 12.20 12.60 14.30 16.50
Cash Flow per Share 2 2.740 5.340 1.650 4.260 9.770 5.040 5.930 6.630
Capex 1 42.4 59.2 49.7 167 208 225 214 221
Capex / Sales 0.46% 0.7% 0.51% 1.67% 2.01% 2.11% 1.96% 1.96%
Announcement Date 3/4/20 2/24/21 2/23/22 2/28/23 2/20/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Owens & Minor, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
25.09 USD
Average target price
23.86 USD
Spread / Average Target
-4.91%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment Wholesale

1st Jan change Capi.
OWENS & MINOR, INC. Stock Owens & Minor, Inc.
+30.20% 1.92B
HENRY SCHEIN, INC. Stock Henry Schein, Inc.
-3.41% 9.4B
SHIP HEALTHCARE HOLDINGS, INC. Stock Ship Healthcare Holdings, Inc.
-3.90% 1.39B
AS ONE CORPORATION Stock AS ONE Corporation
-7.38% 1.18B
GKHT MEDICAL TECHNOLOGY CO., LTD. Stock GKHT Medical Technology Co., Ltd.
-18.42% 857M
TOKAI CORP. Stock TOKAI Corp.
+0.48% 470M
EXCELSIOR MEDICAL CO., LTD. Stock Excelsior Medical Co., Ltd.
+3.62% 437M
GAUSH MEDITECH LTD Stock Gaush Meditech Ltd
-49.68% 360M
COWEALTH MEDICAL CHINA CO.,LTD. Stock Cowealth Medical China Co.,Ltd.
-24.72% 333M
WIN-PARTNERS CO., LTD. Stock WIN-Partners Co., Ltd.
-2.42% 212M
Medical Equipment Wholesale
  1. Stock Market
  2. Equities
  3. OMI Stock
  4. Financials Owens & Minor, Inc.